5 Best Biotech Stocks To Buy Now

Page 5 of 5

1. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Number of Hedge Fund Holders: 59

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), a biotech firm with headquarters based in California, specializes in enzyme replacement therapies. At the end of Q2, 59 hedge funds were bullish on the company shares with $2.88 billion in aggregate positions. This shows improving investor sentiment from the previous quarter when 56 hedge funds owned stakes in the company.

Baker Bros. Advisors is the largest shareholder in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and holds a stake worth $631.51 million in the company. 

The European Commission recently approved roctaviantm (valoctocogene roxaparvovec), the first gene therapy for adults with severe hemophilia A. With a strong portfolio in bleeding disorders, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has a market cap of close to $17.01 billion and estimated annual revenue near $2.12 billion. 

You can also take a look at the 10 Best Websites To Research Stocks  and 10 Best Undervalued Dividend Stocks to Buy Now.

Page 5 of 5